Literature DB >> 16713495

Hereditary polyuric disorders: new concepts and differential diagnosis.

Daniel G Bichet1.   

Abstract

The identification, characterization, and mutational analysis of genes coding for key proteins to the mechanisms of urine concentration provide the basis for understanding the 2 types of hereditary nephrogenic diabetes insipidus (NDI): a pure type characterized by loss of water only, and a complex type characterized by loss of water and ions. Patients with hereditary NDI bearing mutations in AVPR2, the gene coding for the arginine vasopressin 2 receptor, or in AQP2, the gene coding for the vasopressin-sensitive water channel, have a pure NDI phenotype with loss of water, but normal conservation of sodium, potassium, chloride, and calcium. Patients bearing inactivating mutations in 1 of the 5 genes (SLC12A1, KCNJ1, CLCNKB, CLCNKA, and CLCNKB in combination, or BSND) that encode the membrane proteins of the thick ascending limb of the loop of Henle have a complex polyuro-polydipsic syndrome with loss of water, sodium, chloride, calcium, magnesium, and potassium. The purpose of this article is to increase the general awareness of these congenital NDI patients to prevent severe episodes of dehydration and provide precise molecular diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713495     DOI: 10.1016/j.semnephrol.2006.02.004

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  12 in total

Review 1.  Aquaporins: translating bench research to human disease.

Authors:  A S Verkman
Journal:  J Exp Biol       Date:  2009-06       Impact factor: 3.312

Review 2.  Aquaporins in clinical medicine.

Authors:  A S Verkman
Journal:  Annu Rev Med       Date:  2012       Impact factor: 13.739

Review 3.  New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells.

Authors:  Dennis Brown; Richard Bouley; Teodor G Păunescu; Sylvie Breton; Hua A J Lu
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-28       Impact factor: 4.249

Review 4.  Vasopressin and the regulation of aquaporin-2.

Authors:  Justin L L Wilson; Carlos A Miranda; Mark A Knepper
Journal:  Clin Exp Nephrol       Date:  2013-04-13       Impact factor: 2.801

5.  Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation.

Authors:  Baoxue Yang; Dan Zhao; A S Verkman
Journal:  FASEB J       Date:  2008-10-14       Impact factor: 5.191

Review 6.  Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

Authors:  Hanne B Moeller; Søren Rittig; Robert A Fenton
Journal:  Endocr Rev       Date:  2013-01-29       Impact factor: 19.871

Review 7.  Aquaporins: important but elusive drug targets.

Authors:  Alan S Verkman; Marc O Anderson; Marios C Papadopoulos
Journal:  Nat Rev Drug Discov       Date:  2014-03-14       Impact factor: 84.694

Review 8.  Aquaporin-2 regulation in health and disease.

Authors:  M Judith Radin; Ming-Jiun Yu; Lene Stoedkilde; R Lance Miller; Jason D Hoffert; Jorgen Frokiaer; Trairak Pisitkun; Mark A Knepper
Journal:  Vet Clin Pathol       Date:  2012-11-06       Impact factor: 1.180

Review 9.  Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.

Authors:  Hannsjörg W Seyberth; Karl P Schlingmann
Journal:  Pediatr Nephrol       Date:  2011-04-19       Impact factor: 3.714

10.  A de novo novel missense mutation in AVPR2 with severe nephrogenic diabetes insipidus.

Authors:  Daisuke Kobayashi; Shashi K Nagaraj; Jen-Jar Lin; Daniel G Bichet
Journal:  NDT Plus       Date:  2010-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.